OF THE
TIMES
The simple blood test can help to objectively diagnose patients suffering from Post-Acute Sequelae of COVID-19 (PASC), commonly known as Long Covid. Developed by IncellDx, the test will be available to prescribers and patients in September through one of the world's largest providers of diagnostic services.
A CE Mark indicates that the incellKINE Long Covid In Vitro Diagnostic fulfills the requirements of relevant European product directives and meets all the requirements of the relevant recognised European harmonised performance and safety standards...
Comment: Today's medical studies are all just fudging numbers to get the results the authors want. They'll do whatever manipulations they need to downplay negative effects and create 'benefits' where none actually exist. Very few can be trusted (doubly so for those that get a lot of mainstream press attention).
See also: